EBITDA for Acorda Therapeutics Reaches Three Year Low
Stock Quote:(NasdaqNM:ACOR)
11/13/2009
26.41
-0.03
-0.11%
356,327
EBITDA for Acorda Therapeutics Reaches Three Year Low
Last
Price Change
% Chg
Volume
New York, NY, November 13, 2009-Ebitda News reports that negative EBITDA for Acorda Therapeutics, Inc. (NASDAQ:ACOR) for its twelve months ended September 30, 2009 was $(76,966,656), a 26% deteriorati ... read full story
U.S. markets ended a choppy session with modest gains as investors awaited news regarding a Greek austerity deal. It remains unclear whether Greek Prime Minister Lucas Papademos can get politicians to accept the tough austerity policies. According to ... read full story
-0.03 
